Navigation Links
SoluLinK Introduces New One-Shot ChromaLink(TM) Biotin Antibody Labeling Kit with Built-in Biotin Quantification.
Date:10/1/2008

SAN DIEGO, Oct. 1 /PRNewswire/ -- SoluLinK, Inc., a leader in conjugation products and complete easy to use kits, announces the introduction of its newest product, the One-Shot ChromaLink Antibody Labeling Kit. This innovative kit includes all the components for the rapid traceable biotinylation of a single antibody. The kit features SoluLinK's patented sulfo-ChromaLink Biotin linker, a water-soluble, biotin labeling reagent that allows rapid and direct, non-destructive quantification of incorporated biotin.
(Photo: http://www.newscom.com/cgi-bin/prnh/20081001/LAW044)

-- Complete Kit: Comes complete with all necessary reagents and a

foolproof protocol and reference materials conveniently located on a

flash drive in the kit.

-- Built-in Quantitative Signal: Incorporated biotin is quantified using

a simple UV-scan -- no HABA or Fluoro-reporter assay needed.

-- Cost-Effective and Efficient: Biotinylates 100 ug of a single antibody

with up to 80% recovery.

-- Safe and Green: Water-soluble and mild on antibodies -- no DMF or

other organic solvents needed.

-- Inexpensive

"The One-Shot ChromaLink Biotin Antibody Labeling Kit is the first in a new line of SoluLinK products designed to address unmet market needs in detection with effective and proven conjugation technology, supplied in a complete, easy-to-use format. SoluLinK's innovative bioconjugation technology has contributed to our customers' and collaborators' ability to easily build greater value into their efforts and products. With SoluLinK's product advantages in quantification, control, stability and growing patent portfolio, SoluLinK has established a strong leadership position in bioconjugation," observed Leo Mendoza, Director of Product Development for SoluLinK.

About SoluLinK

SoluLinK is the leader in the development of conjugation reagents, easy-to-use complete kits, and conjugation services for the life science research, diagnostics, and pharmaceutical communities. These proprietary products and services provide unique features and benefits used to link proteins, oligonucleotides, peptides, and antibodies to each other or to a wide range of surfaces. SoluLinK's proprietary ChromaLink Biotin One-Shot Antibody Labeling Kit is just one example. This is the second in a pipeline of new, easy-to-use labeling kits intended to enhance assay performance and measurement for customers in a broad range of markets. SoluLinK markets its products both directly and through distributors and licensing partners world-wide. SoluLinK is a privately held company located in San Diego, California. For more information, please visit http://www.solulink.com.


'/>"/>
SOURCE SoluLinK, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. SoluLinK Introduces ChromaLink(TM) Biotin Labeling Kit to Biotinylate and Measure With One Reagent
2. SoluLinK Introduces NanoLink(TM) Streptavidin Magnetic Microspheres
3. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
4. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
5. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
6. Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
7. Advanced Instruments Introduces Worlds Fastest High Throughput Freezing Point Osmometer
8. Harmonex Introduces CliniCom(TM), a Breakthrough in Psychiatric Intake and Assessment Technology
9. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
10. Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments
11. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
(Date:6/22/2016)... June 22, 2016 Research and Markets has ... report to their offering. ... 2014 from $29.3 billion in 2013. The market is expected to ... from 2015 to 2020, increasing from $50.6 billion in 2015 to ... forecasts during the forecast period (2015 to 2020) are discussed. As ...
(Date:6/22/2016)... 2016   ViaCyte, Inc. , a privately-held regenerative ... replacement therapy for the treatment of diabetes in clinical-stage ... Meeting.  ISSCR 2016, the Global Stem Cell Event, is ... in San Francisco.    ... follows:Event: , Focus Session: Tools for Basic and Applied ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):